93 related articles for article (PubMed ID: 19902153)
1. [Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)].
Jensen B; Nitschmann S; Häussinger D
Internist (Berl); 2009 Dec; 50(12):1425-6. PubMed ID: 19902153
[No Abstract] [Full Text] [Related]
2. Effect of early versus deferred antiretroviral therapy for HIV on survival.
Kitahata MM; Gange SJ; Abraham AG; Merriman B; Saag MS; Justice AC; Hogg RS; Deeks SG; Eron JJ; Brooks JT; Rourke SB; Gill MJ; Bosch RJ; Martin JN; Klein MB; Jacobson LP; Rodriguez B; Sterling TR; Kirk GD; Napravnik S; Rachlis AR; Calzavara LM; Horberg MA; Silverberg MJ; Gebo KA; Goedert JJ; Benson CA; Collier AC; Van Rompaey SE; Crane HM; McKaig RG; Lau B; Freeman AM; Moore RD;
N Engl J Med; 2009 Apr; 360(18):1815-26. PubMed ID: 19339714
[TBL] [Abstract][Full Text] [Related]
3. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.
Justice AC; Modur SP; Tate JP; Althoff KN; Jacobson LP; Gebo KA; Kitahata MM; Horberg MA; Brooks JT; Buchacz K; Rourke SB; Rachlis A; Napravnik S; Eron J; Willig JH; Moore R; Kirk GD; Bosch R; Rodriguez B; Hogg RS; Thorne J; Goedert JJ; Klein M; Gill J; Deeks S; Sterling TR; Anastos K; Gange SJ;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):149-63. PubMed ID: 23187941
[TBL] [Abstract][Full Text] [Related]
4. Timing of initiation of antiretroviral drugs during tuberculosis therapy.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray A; Gengiah T; Nair G; Bamber S; Singh A; Khan M; Pienaar J; El-Sadr W; Friedland G; Abdool Karim Q
N Engl J Med; 2010 Feb; 362(8):697-706. PubMed ID: 20181971
[TBL] [Abstract][Full Text] [Related]
5. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
6. Early versus deferred antiretroviral therapy for HIV.
Hernán MA; Robins JM
N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
[No Abstract] [Full Text] [Related]
7. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
[TBL] [Abstract][Full Text] [Related]
8. When to start antiretroviral therapy--ready when you are?
Sax PE; Baden LR
N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
[No Abstract] [Full Text] [Related]
9. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
; Lundgren JD; Babiker A; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips AN
J Infect Dis; 2008 Apr; 197(8):1145-55. PubMed ID: 18476293
[TBL] [Abstract][Full Text] [Related]
10. HIV survival benefit associated with earlier antiviral therapy.
Mocroft A; Phillips AN; Lundgren JD
Ann Intern Med; 2004 Apr; 140(7):578-9; author reply 579. PubMed ID: 15068990
[No Abstract] [Full Text] [Related]
11. Should we be initiating antiretroviral therapy earlier? An argument in favour.
Wood R
S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
[No Abstract] [Full Text] [Related]
12. [Timing of initiation of antiretroviral therapy in HIV-1-infected patients. Meta-analysis of the When To Start Consortium].
Goebel FD; Nitschmann S
Internist (Berl); 2010 Apr; 51(4):539-41. PubMed ID: 20237749
[No Abstract] [Full Text] [Related]
13. Early versus deferred antiretroviral therapy for HIV.
Buchbinder SP; Jain V
N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
[No Abstract] [Full Text] [Related]
14. When to start antiretroviral therapy.
Kitahata MM
Top HIV Med; 2010; 18(3):121-6. PubMed ID: 20921578
[TBL] [Abstract][Full Text] [Related]
15. Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America.
Cesar C; Koethe JR; Giganti MJ; Rebeiro P; Althoff KN; Napravnik S; Mayor A; Grinsztejn B; Wolff M; Padgett D; Sierra-Madero J; Gotuzzo E; Sterling TR; Willig J; Levison J; Kitahata M; Rodriguez-Barradas MC; Moore RD; McGowan C; Shepherd BE; Cahn P;
J Int AIDS Soc; 2016; 19(1):20684. PubMed ID: 26996992
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis.
Szczech LA; Kalayjian R; Rodriguez R; Gupta S; Coladonato J; Winston J;
Kidney Int; 2003 Jun; 63(6):2295-301. PubMed ID: 12753321
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.
Schackman BR; Freedberg KA; Weinstein MC; Sax PE; Losina E; Zhang H; Goldie SJ
Arch Intern Med; 2002 Nov; 162(21):2478-86. PubMed ID: 12437408
[TBL] [Abstract][Full Text] [Related]
18. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
19. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
; Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Lane HC; Phillips AN; Neaton JD
N Engl J Med; 2015 Aug; 373(9):795-807. PubMed ID: 26192873
[TBL] [Abstract][Full Text] [Related]
20. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
